The Feasibility of Ceftolozane/Tazobactam Continuous Infusion for Exacerbations of Cystic Fibrosis and Bronchiectasis Treated in an Outpatient Parenteral Antibiotic Therapy (OPAT) Setting
Latest Information Update: 15 Sep 2023
At a glance
- Drugs Ceftolozane/tazobactam (Primary)
- Indications Burkholderia cepacia infections; Pseudomonal infections
- Focus Therapeutic Use
- Acronyms CERTAIN
Most Recent Events
- 15 Sep 2023 New trial record